Determination of Antibody Responses of Elderly Adults to All 23 Capsular Polysaccharides after Pneumococcal Vaccination

The 23-valent pneumococcal polysaccharide vaccine was formulated to prevent invasive infection in the elderly and other high-risk populations from the most prevalent Streptococcus pneumoniae serotypes. However, the immunogenicity of all 23 vaccine polysaccharides has not been fully characterized in...

Descripció completa

Dades bibliogràfiques

Publicat a:	Infect Immun
Autors principals:	Rubins, Jeffrey B., Alter, Michael, Loch, Joyce, Janoff, Edward N.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1999
Matèries:	Microbial Immunity and Vaccines
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC96983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10531257/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.11.5979-5984.1999
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!